Roche Holding AG (RHHBF) は上場企業です ヘルスケア セクターの 製薬 業界で事業展開. 本社所在地は Basel, スイス. 現CEOは Thomas Schinecker.
RHHBF を有する IPO日 2012-08-03, 103,249 名の正社員, に上場 Other OTC, 時価総額 $333.13B.
Roche Holding AG is a Swiss-based pharmaceutical and diagnostics company founded in 1896 and headquartered in Basel. The company develops and markets pharmaceutical products across multiple therapeutic areas including oncology, neuroscience, immunology, cardiovascular, ophthalmology, and respiratory diseases, as well as treatments for conditions such as cancer, hemophilia, and inflammatory disorders. Roche also operates a substantial diagnostics business providing in vitro testing for disease diagnosis, including cancer, diabetes, COVID-19, and hepatitis, alongside diagnostic instruments and reagents. With operations spanning Switzerland, Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and other international markets, Roche maintains research collaborations to develop innovative therapies, including synthetic biologics for inflammatory bowel disease treatment.
